Testing and Documentation. Nordion shall maintain accurate and complete production records with respect to the Process, Batches and shipments and Molecular Insight Pharmaceuticals shall have access to such records in order to determine that each Batch was produced and tested in compliance with the Specifications and cGMP requirements. The tests and analyses provided in the Specifications as well as the nature and form of records may be amended by Nordion from time to time, subject to the consent of Molecular Insight Pharmaceuticals, which shall not be unreasonably withheld after Nordion shall have delivered to Molecular Insight Pharmaceuticals, in writing, an explanation of such changes and why they are necessary or advisable.
Appears in 2 contracts
Sources: Confidentiality Agreement (Molecular Insight Pharmaceuticals, Inc.), Confidentiality Agreement (Molecular Insight Pharmaceuticals, Inc.)